leisure time -WSS

leisure time

author：entertainment 2025-09-28 12:10:16 - browse：64

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Data show record exodus of life scientists from academia

focus

explore

WSS

Menendez indictment could see pharma lose a key ally

For AI in health care standards, federal regulators join with industry group

Stem cell biologist probes earliest stages of human development

Data show record exodus of life scientists from academia

Change Healthcare: What is it, why does its cyberattack matter?

STAT Virtual Event: How to Increase Diversity in Clinical Trials

focus

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Listen: Who gets the credit for GLP

What does generative AI mean for health care? We asked experts

Microsoft's Peter Lee: Generative AI could help doctors be more human

BioMarin wins approval for gene therapy to treat hemophilia A

Longer MASH drug regimen improved liver, Akero study finds

Hollywood unions extend contract negotiations for actors

Would Medicare drug price negotiations stall in a shutdown?

After affirmative action ruling, medical educators look to 'holistic review'

Intercept Pharmaceuticals sells itself for less than $1 billion

focus

How the Dana

Researchers use wearables data and AI to predict preterm birth risk

The public health thinking behind the CDC’s new Covid guidance

Medicare drug price negotiation program allowed for now

Address the ethical violations that led to 'Three Identical Strangers'

After a drawn out lobbying fight, ARPA

entertainment

focus

explore

entertainment